Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients

Journal of Lipid Research

Volumn 44, Issue 4, 2003, Pages 754-761

  Drobnik, Wolfgang ^a   Liebisch, Gerhard ^a   Audebert, Franz Xaver ^a   Fröhlich, Dieter ^a   Glück, Thomas ^a   Vogel, Peter ^a   Rothe, Gregor ^a   Schmitz, Gerd ^a  

^a NONE

Author keywords

Lipoproteins; Outcome; Phospholipase; Prognostic marker; SAPS score; Sphingomyelinase

Indexed keywords

ANTIBIOTIC AGENT; CERAMIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; SPHINGOMYELIN;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME MECHANISM; FEMALE; HUMAN; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOLECULE; MORTALITY; NONHUMAN; PRECURSOR; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SEPSIS; SPECIES; SPECIES DIFFERENCE; STATISTICAL ANALYSIS; TANDEM MASS SPECTROMETRY;

EID: 0142074218     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200401-JLR200     Document Type: Article

References (28)

1. Bulger, E. M., and R. V. Maier. 2000. Lipid mediators in the pathophysiology of critical illness. Crit. Care Med. 28: N27-N36.
2. Kabarowski, J. H., Y. Xu, and O. N. Witte. 2002. Lysophosphatidylcholine as a ligand for immunoregulation. Biochem. Pharmacol. 64: 161-167.
3. Kume, N., M. I. Cybulsky, and M. A. Gimbrone, Jr. 1992. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90: 1138-1144.
4. Kume, N., and M. A. Gimbrone, Jr. 1994. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J. Clin. Invest. 93: 907-911.
5. Jing, Q., S. M. Xin, W. B. Zhang, P. Wang, Y. W. Qin, and G. Pei. 2000. Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis. Circ. Res. 87: 52-59.
6. Yamamoto, N., S. Homma, and I. Millman. 1991. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages. J. Immunol. 147: 273-280.
7. Koh, J. S., Z. Wang, and J. S. Levine. 2000. Cytokine dysregulation induced by apoptotic cells is a shared characteristic of murine lupus. J. Immunol. 165: 4190-4201.
8. Lusis, A. J. 2000. Atherosclerosis. Nature. 407: 233-241.
9. Delogu, G., G. Famularo, F. Amati, L. Signore, A. Antonucci, V. Trinchieri, L. Di Marzio, and M. G. Cifone. 1999. Ceramide concentrations in septic patients: a possible marker of multiple organ dysfunction syndrome. Crit. Care Med. 27: 2413-2417.
10. Wright, S. D., and R. N. Kolesnick. 1995. Does endotoxin stimulate cells by mimicking ceramide? Immunol. Today. 16: 297-302.
11. Pfeiffer, A., A. Bottcher, E. Orso, M. Kapinsky, P. Nagy, A. Bodnar, I. Spreitzer, G. Liebisch, W. Drobnik, K. Gempel, M. Horn, S. Holmer, T. Hartung, G. Multhoff, G. Schutz, H. Schindler, A. J. Ulmer, H. Heine, F. Stelter, C. Schutt, G. Rothe, J. Szollosi, S. Damjanovich, and G. Schmitz. 2001. Lipopolysaccharide and ceramide docking to CD14 provokes ligand- specific receptor clustering in rafts. Eur. J. Immunol. 31: 3153-3164.
12. Bone, R. C., R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein, and W. J. Sibbald. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 101: 1644-1655.
13. Murray, P. 1999. Manual of Clinical Microbiology, 7th edition. American Society for Microbiology, Washington, DC.
14. Bligh, E. G., and W.J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Phys. 37: 911-917.
15. Liebisch, G., W. Drobnik, M. Reil, B. Trumbach, R. Arnecke, B. Olgemoller, A. Roscher, and G. Schmitz. 1999. Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS/MS). J. Lipid Res. 40: 1539-1546.
16. Liebisch, G., W. Drobnik, B. Lieser, and G. Schmitz. 2002. High throughput quantification of lysophosphatidylcholine by electrospray ionization tandem mass spectrometry. Clin. Chem. 48: 2217-2224.
17. Vuong, T. D., S. de Kimpe, R. de Roos, T. J. Rabelink, H. A. Koomans, and J. A. Joles. 2001. Albumin restores lysophosphatidylcholine-induced inhibition of vasodilation in rat aorta. Kidney Int. 60: 1088-1096.
18. Schissel, S. L., G. A. Keesler, E. H. Schuchman, K.J. Williams, and I. Tabas. 1998. The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J. Biol. Chem. 273: 18250-18259.
19. Marathe, S., S. L. Schissel, M. J. Yellin, N. Beatini, R. Mintzer, K. J. Williams, and I. Tabas. 1998. Human vascular endothelial cells are a rich and regulatable source of secretory sphingomyelinase. Implications for early atherogenesis and ceramide-mediated cell signaling. J. Biol. Chem. 273: 4081-4088.
20. Wong, M. L., B. Xie, N. Beatini, P. Phu, S. Marathe, A. Johns, P. W. Gold, E. Hirsch, L. J. Williams, J. Licinio, and I. Tabas. 2000. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. Proc. Natl. Acad. Sci. USA. 97: 8681-8686.
21. Schissel, S. L., X. Jiang, J. Tweedie-Hardman, T. Jeong, E. H. Camejo, J. Najib, J. H. Rapp, K. J. Williams, and I. Tabas. 1998. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J. Biol. Chem. 273: 2738-2746.
22. Grassme, H., V. Jendrossek, J. Bock, A. Riehle, and E. Gulbins. 2002. Ceramide-rich membrane rafts mediate CD40 clustering. J. Immunol. 168: 298-307.
23. Kabarowski, J. H., K. Zhu, L. Q. Le, O. N. Witte, and Y. Xu. 2001. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science. 293: 702-705.
24. Le, L. Q., J. H. Kabarowski, Z. Weng, A. B. Satterthwaite, E. T. Harvill, E. R. Jensen, J. F. Miller, and O. N. Witte. 2001. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity. 14: 561-571.
25. Tokumura, A. 2002. Physiological and pathophysiological roles of lysophosphatidic acids produced by secretory lysophospholipase D in body fluids. Biochim. Biophys. Acta. 1582: 18-25.
26. Graler, M. H., and E.J. Goetzl. 2002. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim. Biophys, Acta. 1582: 168-174.
27. Goetzl, E. J., Y. Kong, and J. K. Voice. 2000. Cutting edge: differential constitutive expression of functional receptors for lysophosphatidic acid by human blood lymphocytes. J. Immunol. 164: 4996-4999.
28. Zheng, Y., J. K. Voice, Y. Kong, and E. J. Goetzl. 2000. Altered expression and functional profile of lysophosphatidic acid receptors in mitogen-activated human blood T lymphocytes. FASEB J. 14: 2387-2389.